Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-04-15

FDA Approved: RUFINAMIDE — Original Application (Novadoz Pharmaceuticals LLC)

View source ↗

Summary

FDA approved Rufinamide from Novadoz Pharmaceuticals LLC through an Original Abbreviated New Drug Application.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rufinamide (Rufinamide)

Snippet

ORIG AP for RUFINAMIDE (RUFINAMIDE)